Problem With Growth of an Infant Clinical Trial
Official title:
The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU
| Verified date | January 2018 |
| Source | University of Nebraska |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The investigators hypothesis that premature infants receiving a commercially available liquid protein modular will have improved growth when compared with premature infants receiving a commercially available powder protein modular.
| Status | Completed |
| Enrollment | 60 |
| Est. completion date | June 2013 |
| Est. primary completion date | June 2013 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A to 40 Weeks |
| Eligibility |
Inclusion Criteria: - Infants less than 2000 gms at birth, receiving maternal breast milk Exclusion Criteria: - Infants receiving formula |
| Country | Name | City | State |
|---|---|---|---|
| United States | Alegent Bergan Hospital | Omaha | Nebraska |
| Lead Sponsor | Collaborator |
|---|---|
| University of Nebraska | Alegent Health Bergan Mercy Medical Center |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Growth in premature infants (percentile ranking at 36 weeks CGA) | birth to 36 weeks | ||
| Secondary | GI tolerance | abdominal distention, feeding tolerance | birth to 36 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02681289 -
Physiotherapy of At-Risk Infants, Physiotherapist or Family?
|
N/A | |
| Recruiting |
NCT04817878 -
Cohort Construction for Preterm Infants With Growth Retardation and Its Influencing Factors
|